EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT07064473 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

11800

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Hypertension
Cardiovascular Diseases

Interventions

DRUG: Vicadrostat
DRUG: Empagliflozin
DRUG: Placebo matching Vicadrostat

Sponsor

Boehringer Ingelheim